13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-02-14, with 47 holding rows worth $97,156,000.
- Accession
- 0001389933-14-000001
- Filer
- CIK 1389933
- Filed
- 2014-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2013
A holdings report, 47 entries on the cover page, a total value of $97,156,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $97,156,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DISCOVERY LABORATORIES INC N | 254668403 | COM NEW | 5,698,739 | $12,822,000 | thousands by filing date | |
| PHARMACYCLICS INC | 716933106 | COM | 108,628 | $11,491,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 456,701 | $8,531,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,738,498 | $6,293,000 | thousands by filing date | |
| GIVEN IMAGING LTD | M52020100 | ORD | 156,320 | $4,702,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 284,041 | $4,684,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 1,178,440 | $4,584,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 121,481 | $4,507,000 | thousands by filing date | |
| INSULET CORP | 45784PAC5 | CNV | 3,000,000 | $4,370,000 | thousands by filing date | principal |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 384,154 | $3,842,000 | thousands by filing date | |
| Ampio Pharmaceuticals | 03209T109 | COM | 425,703 | $3,035,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 342,453 | $1,826,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 215,645 | $1,712,000 | thousands by filing date | |
| BIOTA PHARMACEUTIALS INC | 090694100 | COM | 327,190 | $1,371,000 | thousands by filing date | |
| THRESHOLD PHARMACEUTICAL INC | 885807206 | COM NEW | 280,500 | $1,310,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 52,362 | $1,309,000 | thousands by filing date | |
| VENAXIS INC | 92262A107 | COM | 590,000 | $1,263,000 | thousands by filing date | |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 51,692 | $1,120,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 90,947 | $1,119,000 | thousands by filing date | |
| NUVASIVE INC | 670704AC9 | CORPORATE OBLIG | 1,000,000 | $1,092,000 | thousands by filing date | principal |
| CARDICA INC | 14141R101 | COM | 1,063,469 | $1,037,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 177,362 | $1,020,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 111,245 | $928,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 88,694 | $903,000 | thousands by filing date | |
| CONATUS PHARMACEUTICALS INC | 20600T108 | COM | 135,666 | $875,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 9,400 | $861,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 63,223 | $821,000 | thousands by filing date | |
| ADAMIS PHARMACEUTICALS CORP | 00547W208 | COM NEW | 125,000 | $799,000 | thousands by filing date | |
| UROPLASTY INC | 917277204 | COM NEW | 289,332 | $790,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 12,600 | $759,000 | thousands by filing date | |
| EXACTECH INC | 30064E109 | COM | 31,636 | $752,000 | thousands by filing date | |
| INSPIREMD INC | 45779A309 | COM | 286,724 | $705,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 9,598 | $655,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 57,009 | $617,000 | thousands by filing date | |
| RTI BIOLOGICS INC | 74975N105 | COM | 167,058 | $591,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 44,000 | $570,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 75,500 | $569,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158102 | COM | 290,000 | $568,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 17,500 | $512,000 | thousands by filing date | |
| CURIS INC | 231269101 | COM | 150,000 | $423,000 | thousands by filing date | |
| BAXANO SURGICAL | 071773105 | COM | 336,351 | $340,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 75,000 | $293,000 | thousands by filing date | |
| SYNTHETIC BIOLOGICS INC | 87164U102 | COM | 184,900 | $283,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 344,690 | $253,000 | thousands by filing date | |
| CHEMBIO DIAGNOSTICS | 163572209 | COM | 55,202 | $186,000 | thousands by filing date | |
| RETRACTABLE TECHNOLOGIES INC | 76129W105 | COM | 20,000 | $62,000 | thousands by filing date | |
| COMBIMATRIX CORP | 20009T121 | *W EXP 05/01/201 | 2,325 | $1,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-14-000001 | this filing | 2014-02-14 | acceptance time not in the bulk data set |